February 23, 2026 · Form 4 insider transaction
Snyder Mark Howard bought 7,011 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.